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Introduction
The poor clinical outcome of many cancers is caused by dis-
semination of metastatic tumor cells and the outgrowth of 
secondary tumors at distant sites. To metastasize, cancer cells 
must cross ECM barriers, such as basement membranes and 
the stromal tissue that surrounds tumors, as well as acquire 
the ability to extravasate and insinuate themselves into their 
metastatic target organs (Sahai, 2005; Rowe and Weiss, 2009). 
Many of these steps to metastasis require cancer cells to 
acquire particular migratory characteristics, and this issue is now 
becoming a major focus for researchers keen to understand 
how cancer progresses.
A cell’s migratory properties depend on the way in which 
it interacts with and responds to the surrounding ECM, and 
much of this is dictated by the integrin family of ECM recep-
tors. Integrins are heterodimeric transmembrane receptors that 
not only physically link the intracellular actin cytoskeleton to 
the ECM but are also signaling molecules that transduce signals 
bidirectionally across the plasma membrane (Hynes, 2002). 
There are several ways in which a cell can control integrin 
behavior. For instance, FERM domain–containing proteins, 
such as talin and kindlin, can be recruited to integrin cytotails to 
activate their ECM ligand-binding capacity (Moser et al., 2009). 
Moreover, surface integrins are continuously endocytosed and 
then returned (or recycled) back to the plasma membrane, and it 
is now apparent that the way in which integrins are trafficked 
through the endosomal pathway is key to how they function 
(Caswell and Norman, 2006, 2008; Pellinen and Ivaska, 2006; 
Ramsay et al., 2007; Caswell et al., 2009). There is a reciprocal 
relationship between the trafficking of v3 and 51 integrins 
such that when v3 cycling or ligand engagement is compro-
mised, recycling of 51 integrin is strongly promoted (White 
et al., 2007; Caswell et al., 2008). Furthermore, it is now clear 
that oncogenic mutant forms of p53 strongly promote 51 
recycling and that this is achieved via mutant p53’s ability to 
inhibit p63 function (Muller et al., 2009). Importantly, whether 
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regulators of endocytosis or recycling (Pelkmans et al., 2005). 
In T cells, DGK- may be required for multivesicular body 
polarization and exosome release (Alonso et al., 2011), and 
knockdown of DGK- has been shown to promote transferrin 
recycling (Rincón et al., 2007). In addition, DGK- suppresses 
endoplasmic reticulum to Golgi traffic in epithelial cells (Nagaya 
et al., 2002). Conversely, DGKs have been largely ruled out as the 
source of PA required for Golgi coatomer recruitment (Yang 
et al., 2008).
Here, we show that DGK- is required to support RCP-
dependent 51 integrin recycling. Moreover, the migratory 
consequences of this RCP-regulated trafficking event (such 
as the acquisition of random migration on 2D surfaces and in-
vasion into fibronectin-containing 3D matrices) are DGK- 
dependent. Consistently, RCP must be capable of binding to PA 
to be mobilized to and tethered at the tips of invasive pseudo-
pods, and expression of a constitutively active mutant of DGK-
 is sufficient to drive RCP-dependent invasiveness. Our data 
suggest that by providing a source of PA to maintain RCP func-
tion, DGK- forms an essential component of the pathway by 
which mutant p53s drive tumor cell invasion.
Results
DGK- is required for RCP-dependent  
51 recycling
We have previously shown that inhibition of v3 integrin or 
expression of oncogenic mutants of p53 (such as p53175H or 
p53273H) increases the rate at which internalized 51 integrin 
is returned to the plasma membrane; an event that requires re-
cruitment of RCP to the integrin (Caswell et al., 2008; Muller 
et al., 2009). Given the presence of a PA-binding C2 domain 
within the N-terminal region of RCP, we investigated whether 
DGK- was required for RCP-dependent integrin trafficking. We 
treated A2780 ovarian carcinoma cells with either cRDGfNMeV 
or cRGDfV (cyclic peptides known to bind to and inhibit v 
integrins; Dechantsreiter et al., 1999) and measured the rate at 
which internalized 51 returned to the plasma membrane. Con-
sistent with our previous observations, addition of cRGDfNMeV 
(Fig. 1, A and B) or cRGDfV (Fig. 1 C) enhanced the rate at which 
51 was recycled to the plasma membrane. This enhance-
ment of 51 recycling was completely opposed by siRNA of 
DGK- (Figs. 1 A and S1) or treatment of cells with low con-
centration of the class I DGK inhibitor, R59949 (Fig. 1 B; 
Jiang et al., 2000), indicating that enzymatic activity of DGK- 
was required. Moreover, the ability of DGK- knockdown 
to oppose 51 recycling was negated by expression of an 
siRNA-resistant rescue mutant of DGK- (Figs. 1 C and S1 A). 
Accordingly, we found that addition of R59949 significantly 
inhibited 51 recycling in H1299 lung carcinoma cells 
expressing the 273H mutant of p53 but did not diminish inte-
grin recycling in p53-null H1299 cells (Fig. 1 D). DGK- 
knockdown did not inhibit 125I-transferrin recycling—an RCP-
independent event in A2780 and H1299 cells (Caswell et al., 
2008; Muller et al., 2009)—although the return of internalized 
125I-transferrin to the plasma membrane was opposed by addi-
tion of receptor recycling inhibitors, such as chloroquine or 
achieved by v3 inhibition or by expression of mutant p53s, 
the migratory consequences of increased 51 recycling de-
pend on the ECM environment. Thus, when cells are plated 
onto 2D surfaces, increased 51 recycling causes cells to 
switch from directional to random migration (White et al., 2007; 
Caswell et al., 2008). On the other hand, when tumor cells are 
in 3D microenvironments, activated 51 recycling promotes 
the extension of invasive pseudopodial structures, leading to 
increased invasiveness of the type associated with metastatic 
cancers (Caswell et al., 2008; Muller et al., 2009).
Small GTPases of the Rab11 family, including Rab11a 
and Rab25, are known to regulate 51 recycling (Roberts et al., 
2001; Caswell et al., 2007). The Rab11 family–binding pro-
teins, known as the Rab11–family-interacting proteins (FIPs), are 
key to Rab11 function (Prekeris, 2003; Horgan and McCaffrey, 
2009), and recently, we have established that one of these, 
Rab-coupling protein (RCP), is required to link expression of 
mutant p53 (and inhibition of v3) to increased 51 recy-
cling (Caswell et al., 2008; Muller et al., 2009). Furthermore, 
the migratory consequences of increased 51 recycling, such as 
increased invasiveness and the acquisition of random migration, 
depend on RCP and its ability to recruit 51. Consistent with 
this, RCP has recently been identified to be located within a 
genomic region (8p11-12) that is frequently amplified in breast 
cancer and to contribute to the progression of certain forms of 
this disease (Zhang et al., 2009). The class I Rab11-FIPs (Rip11, 
RCP, and Rab11-FIP2) contain a C2 domain at the N-terminal 
end of the protein, and this has been shown to bind to the acidic 
phospholipids, phosphatidic acid (PA) and phosphatidylinositol 
3,4,5-trisphosphate (Lindsay and McCaffrey, 2004). Moreover, 
there are indications that PA synthesis may be required for 
translocation of RCP from perinuclear endosomes to a sub-
plasmalemmal location after treatment of cells with phorbol 
esters (Lindsay and McCaffrey, 2004).
PA serves as an important second messenger that can 
be found at various locations within the cell, including the 
plasma membrane, Golgi, and endosomes, and PA can be pro-
duced in cells by two different enzyme families, diacylglycerol 
kinases (DGKs) and PLDs (Jenkins and Frohman, 2005; Mérida 
et al., 2008). DGKs phosphorylate DAG to yield PA, thereby 
regulating the levels of both these lipid second messengers in 
a reciprocal manner. Thus, DGKs act both as terminators of 
DAG-mediated signals as well as activators of PA-mediated 
ones. DGKs comprise a family of 10 distinct enzymes, grouped 
in five classes each featuring a highly conserved catalytic domain 
preceded by two cysteine-rich C1-like domains and distinct 
regulatory domains (Mérida et al., 2008).
PA generated by activation of either DGKs or PLDs 
mediates cell migration by regulating the function of small 
GTPases through a variety of mechanisms (Nishikimi et al., 
2009; Chianale et al., 2010), and Src-dependent activation of 
DGK- mediates hepatocyte growth factor (HGF)– and VEGF-
induced cell migration by regulating atypical PKCs and Rac 
(Cutrupi et al., 2000; Chianale et al., 2007, 2010; Baldanzi et al., 
2008). Several lines of evidence indicate that DGKs are in-
volved in membrane traffic. A large-scale kinome-wide siRNA 
screen has identified three DGKs (, , and ) as potential 
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Figure 1. DGK- is required for 51 recycling in response to v3 inhibition or expression of mutant p53. (A–E) The recycling of internalized 51 
(A–D) or 125I-transferrin (TFN; E) was determined in A2780 (A–C and E) or empty vector and mutant p53-expressing H1299 (D) cells. In A and E, A2780 
cells were transfected with a nontargeting siRNA (siRNA control [si-con]) or an siRNA targeting DGK- (si-DGK). In C, A2780 cells were transfected 
with an siRNA targeting DGK- or siRNA targeting DGK- in combination with an siRNA-resistant DGK- (si-DGK/DGK(resc)) or empty vector control 
(pMT2). (B and D) The DGK inhibitor, 1 µM R59949, or DMSO control was included during the internalization and recycling periods as indicated. (E) 120 µM 
chloroquine (CQ) was included during the internalization and recycling periods, whereas 0.3 mM primaquine (PQ) was only in the recycling period. 
(A–C) 36 nM cRGDfNMeV (A and B) or 2.5 µM cRGDfV (C) was included as indicated during the recycling period. Values are means ± SEM (A–D) and 
means ± SD (E) of at least nine replicates. †††, P < 0.0001 for si-con+cRGDfNMeV versus si-DGK-+cRGDfNMeV; Mann–Whitney test. ***, P < 0.0001 
for si-DGK-+cRGDfNV versus si-DGK-/DGK-(resc)+cRGDfV; Mann–Whitney test. §§, P < 0.0001 for DMSO+cRGDfNMeV versus R59949+cRGDfNMeV; 
Mann–Whitney test. ‡‡‡, P < 0.0001 for p53273H DMSO versus p53273H R59949; Mann–Whitney test. $$$, P = 0.0002 for vehicle versus primaquine/
chloroquine; Mann–Whitney test.
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Figure 2. DGK- is required for cRGDfNMeV- and mutant p53-driven random migration on 2D surfaces. (A) A2780 cells were transfected with GFP-actin 
in combination with either nontargeting siRNA (siRNA control [si-con]) or an siRNA targeting DGK- (si-DGK) and allowed to grow to confluence on glass 
surfaces. Confluent monolayers were wounded with a plastic pipette tip, and the cells were allowed to migrate into the wound in the absence () or presence 
of 36 nM cRGDfNMeV. Time-lapse videos were recorded (Videos 1, 2, and 3), and representative stills are displayed. Bar, 20 µm. (B) A2780 cells were 
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transfected with nontargeting siRNA or an siRNA targeting DGK-, grown to confluence, and wounded as for A. The cells were observed by time-lapse 
video microscopy, the movement of individual cells was followed using cell-tracking software, and representative trackplots of trajectories described by cells 
during the first 8 h of migration into the wound are presented. (C and D) A2780 cells were transfected with nontargeting siRNA, an siRNA targeting DGK-, 
or siRNA targeting DGK- in combination with siRNA-resistant DGK- (si-DGK/DGK(resc)), and their migration into scratch wounds in the absence () 
or presence of 36 nM cRGDfNMeV or 2.5 µM cRGDfV both with or without 10 µM R59022 or vehicle control (DMSO) was recorded as for B. The forward 
migration index was extracted from the trackplots. (E–G) H1299 cells expressing p53273H or a control vector were transfected as for C and D, and their 
migration into scratch wounds in the presence and absence of 10 µM R59022 or vehicle control (DMSO) was recorded as for B. The forward migration 
index was extracted from the trackplots as for C. (C, D, F, and G) Data are represented as box and whisker plots (black lines shows medians; whiskers: 
5–95 percentile); n = 3 independent experiments. ***, P < 0.0001; Mann–Whitney test.
 
primaquine (Fig. 1 E). Furthermore, internalization of both 51 
(Fig. S1 D) and the transferrin receptor (TfnR; Fig. S1 E) was 
unaffected by DGK- knockdown.
Given the requirement for DGK- in RCP-dependent re-
cycling, we used an in vitro kinase assay to determine whether 
inhibition of v3 or expression of mutant p53 led to increased 
DGK- activity. However, although addition of EGF strongly 
activated both endogenous (Fig. S1 F) and overexpressed myc–
DGK- (Fig. S1 G), neither addition of cRGDfV (or cRGDfNMeV; 
not depicted) nor expression of mutant p53 affected DGK- 
activity (Fig. S1, F and G). We also used immunofluorescence 
to look at the distribution of endogenous DGK- and found that 
the enzyme was distributed diffusely in the cytoplasm in both 
the presence and absence of cRGDfV (Fig. S1 H), consistent 
with the observation that inhibition of v3 does not, per se, 
lead to activation of the kinase (Fig. S1 F).
Inhibition of v3 (Fig. S2 A; Caswell et al., 2008) and 
expression of mutant p53 (Muller et al., 2009) lead to recruit-
ment of RCP to 51 integrin, and this is reflected in an in-
creased ability to coimmunoprecipitate these two proteins. To 
determine whether DGK- was required for association of RCP 
with 51, we expressed GFP-RCP (or GFP control) and immuno-
precipitated with an antibody recognizing GFP. However, in-
hibition of DGK- did not reduce the quantity of 51 that 
coimmunoprecipitated with GFP-RCP after inhibition of v3 
(Fig. S2 A) or expression of mutant p53 (Fig. S2 B). We also 
performed the immunoprecipitation the other way around in 
mutant p53-expressing H1299 cells and found that addition of 
the DGK inhibitor did not affect the quantity of endogenous 
RCP that coimmunoprecipitated with 5 integrin (Fig. S2 C).
Collectively, these data indicate that although DGK- has 
no role in the internalization of 51, its activity is permissive 
for RCP-dependent events that enhance the integrin’s return to 
the cell surface. Moreover, as addition of DGK- inhibitors did 
not influence the ability of RCP to coimmunoprecipitate with 
51 after addition of v3 inhibitors or expression of mutant 
p53 (Fig. S2, A–C), we propose that DGK- acts at a step 
downstream of integrin-RCP association to promote the delivery 
of RCP-51 recycling vesicles to the plasma membrane.
DGK- is required for 51-RCP–driven 
random migration
We have previously shown that increased RCP-dependent 51 
recycling (whether evoked by inhibition of v3 or expression 
of mutant p53s) is associated with a switch from persistent to 
random migration when cells are plated onto 2D surfaces (White 
et al., 2007; Caswell et al., 2008; Muller et al., 2009). We used 
fluorescence time-lapse microscopy to look at the organization 
of the actin cytoskeleton and persistence of cell movement 
during migration into scratch wounds. Consistent with our pre-
vious observations, A2780 (Fig. 2 A) and H1299 (not depicted) 
cells adopted a fanlike morphology as they migrated persis-
tently into wounds (Fig. 2, B–E), and GFP-actin imaging indi-
cated the presence of a stable actin-rich lamellipodium at the 
cell front (Fig. 2 A and Video 1). However, after inhibition of 
v3 (Fig. 2, A–D; and Video 2) or expression of mutant p53 
(Fig. 2, E–G; and not depicted), the ability of cells to maintain 
a stable lamellipodium and to migrate persistently was dis-
rupted; rather, the cells moved randomly while extending highly 
protrusive actin-rich structures in all directions. Indeed, the 
acquisition of random migration was reflected in a marked 
reduction in migratory persistence (Fig. S3, A and B) and a 
lowered forward migration index, a quantitative measure of 
persistent migration perpendicular to the wound’s edge (Fig. 2, 
C, D, F, and G). Interestingly, the ability of cRGDfNMeV and 
cRGDfV (Figs. 2, A–C; and S3 A; and Video 3) or mutant p53 
(Figs. 2, E–G; and S3 B; and not depicted) to disrupt the lamel-
lipodium and induce random migration (i.e., to reduce the for-
ward migration index and migratory persistence) was opposed 
by siRNA or pharmacological inhibition of DGK-. More-
over, random migration was restored in DGK- knockdown 
cells by reexpression of an siRNA-resistant mutant of DGK- 
(Fig. 2, D and F). However, it must be noted that overexpres-
sion of DGK- did lead to a small (but significant) decrease in 
forward migration index, even in the absence of v3 inhibi-
tion (Fig. 2 D). Importantly, knockdown of DGK- had no 
detectable effect on the migratory characteristics of p53-null 
H1299 (H1299 vector) or A2780 cells that were not treated 
with v3 inhibitors (Fig. 2).
DGK- is required to tether RCP vesicles 
at pseudopod tips
When A2780 or H1299 cells are plated into the cell-derived 
matrix (CDM), a planar 3D matrix that recapitulates many of 
the characteristics of native fibrillar fibronectin/collagen-rich 
ECM (Cukierman et al., 2001), they migrate in a sluglike fash-
ion with a relatively broad cell front, and RCP is localized pri-
marily to the cytosol and to vesicles in the cell body (Figs. 3 
and 4). However, inhibition of v3 (Fig. 3, A and B) or ex-
pression of mutant p53 (Fig. 3, C and D) promoted extension 
of long invasive pseudopods in the direction of cell migration, 
and fluorescence live-cell imaging clearly reveals a popula-
tion of RCP vesicles that are recruited to the tips of these 
structures (Fig. 4 and Videos 4 and 6). Furthermore, by co-
expressing GFP-RCP with an untagged mCherry protein, we 
confirmed that pseudopodial enrichment of RCP vesicles did 
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Figure 3. DGK- is required for pseudopod elongation evoked by inhibition of v3 or expression of mutant p53. (A–D) A2780 cells (A and B) or vector 
and p53273H-expressing H1299 cells (C and D) were transfected with nontargeting siRNA (siRNA control [si-con]), an siRNA targeting DGK- (si-DGK) 
or siRNA targeting DGK- in combination with siRNA-resistant DGK- (si-DGK/DGK(resc)) and plated onto CDM. Time-lapse videos were recorded in 
the absence () or presence of 36 nM cRGDvNMeV or 2.5 µM cRGDfV in combination with 10 µM R59022 or its vehicle (DMSO) and 0.5% butan-1-ol 
(But-1-ol; or secondary alcohol control [0.5% butan-2-ol]). Representative stills are displayed. (A and C) The arrows indicate elongated pseudopods. Bars, 
20 µm. In B and D, the distance between the center of the nucleus and the cell front (with respect to the direction of migration) was measured using ImageJ. 
Data are represented as box and whiskers plots (black lines show medians; whiskers: 5–95 percentile); n = 3 independent experiments. ***, P < 0.0001; 
Mann–Whitney test.
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Figure 4. DGK- is necessary for RCP re-
cruitment to pseudopod tips during migration 
on CDM. (A and B) A2780 cells (A) or vector 
and p53273H-expressing H1299 cells (B) were 
transfected with GFP-RCP in combination with 
nontargeting siRNA (siRNA control [si-con]), an 
siRNA targeting DGK- (si-DGK), or siRNA 
targeting DGK- in combination with siRNA-
resistant DGK- (si-DGK/DGK(resc)). Cells 
were plated onto CDM, mounted onto the stage 
of a confocal microscope (FV1000), and incu-
bated in the absence () or presence of 36 nM 
cRGDfNMeV or 2.5 µM cRGDfV. Images were 
captured at one frame/second over a period 
of 60 s, and videos were generated from these 
(Videos 4, 5, 6, and 7). Single-section confocal 
image stills corresponding to individual frames 
from these videos are presented. The arrows 
indicate the direction of migration, and the por-
tion of the cell within the white square is pre-
sented in the bottom images. Bars, 10 µm.
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Figure 5. DGK- is required for the tethering of RCP vesicles at pseudopod tips. (A–C) A2780 (A and B) or vector and p53273H-expressing H1299 cells 
(C) were transfected with GFP-RCP in combination with nontargeting siRNA (siRNA control [si-con]), an siRNA targeting DGK- (si-DGK), or siRNA targeting 
DGK- in combination with siRNA-resistant DGK- (si-DGK/DGK(resc)). Cells were plated onto CDM, mounted onto the stage of a confocal microscope 
(FV1000), and incubated in the absence () or presence of 2.5 µM cRGDfV. Photobleaching was performed as described in the Materials and methods 
section. Stills from a video (Video 8) at the indicated time points are shown. (A) The arrows indicate the direction of cell migration, whereas the circles 
highlight the bleaching region. Recovery curves were generated using the FV10-ASW software (Olympus), and the immobile fraction (percentile) was 
extracted from these. Values are means ± SEM; ***, P < 0.0001. Bar, 10 µm.
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not simply reflect increased cytoplasmic volume within this 
cellular extremity (Fig. S4 A).
The RCP-positive structures at pseudopod tips appeared 
to be relatively immobile, as if a population of GFP-RCP mole-
cules were tethered at the cell front (Videos 4 and 6). To test 
this, we photobleached GFP-RCP at the front of cells and looked 
at the recovery of fluorescence into the photobleached area 
(termed FRAP). When A2780 or H1299 cells were migrating 
on the CDM, GFP-RCP fluorescence recovered quickly and 
completely at the front of photobleached pseudopod tips, in-
dicating that RCP was relatively mobile under these circum-
stances. In contrast, inhibition of v3 (Fig. 5, A and B; 
and Video 8) or expression of mutant p53 (Fig. 5 C) increased 
the proportion of GFP-RCP that was immobile at the pseudo-
pod tip and that did not recover after photobleaching. This 
indicates that the RCP-positive structures at the tips of pseu-
dopods are tightly tethered within this cellular locale and that 
the population of RCP molecules involved in this process do 
not exchange rapidly with those in the cytosol. Moreover, GFP 
that was not conjugated to RCP recovered completely after 
photobleaching, irrespective of whether or not cells had been 
treated with cRGDfV, indicating that inhibition of v3 did 
not nonspecifically affect the mobility of cytosolic proteins 
within the pseudopod tip (Fig. S4 B).
Given that extension of invasive pseudopods depends on 
both 51 and RCP (Caswell et al., 2008), we wished to deter-
mine the requirement for DGK- in this process. Indeed, siRNA 
of DGK- or inhibition of its catalytic activity impaired pseu-
dopodial extension after inhibition of v3 (Fig. 3, A and B) or 
expression of mutant p53 (Fig. 3, C and D). Moreover, DGK- 
knockdown markedly reduced the number of RCP-positive struc-
tures (Fig. 4) and the immobile fraction of GFP-RCP (Fig. 5) at 
pseudopod tips in a way that could be rescued by reexpression 
of siRNA-resistant DGK-. It is interesting to note that DGK- 
knockdown increased the population of RCP vesicles in the 
perinuclear region (Fig. 4) without apparently restricting the 
overall mobility of RCP endosomes within the pseudopod 
shaft (Videos 5 and 7). Importantly, inhibition of DGK- by 
siRNA or pharmacological means did not affect the morphology 
(Figs. 3 and 4) or migration speed (not depicted) of p53-null 
H1299 (H1299 vector) or A2780 cells that were not treated with 
v3 inhibitors.
Influence of DGK- on DAG  
and PA lipid species
Mass spectrometry was used to determine the cellular levels of 
DAG and PA. Table 1 and Table 2 show that suppressing the 
level of DGK- by siRNA reduced the total concentration of 
PA and increased that of DAG; though in each case, the effects 
were relatively small. The DGK inhibitor surprisingly reduced 
cellular DAG and had a minimal effect upon PA. Determination 
of relatively small total cellular lipid concentrations does not 
give a true reflection of changes in lipid-mediated responses 
and their effects upon membranes because individual lipid 
Table 1. Influence of DGK- on total DAG and PA lipid content
Sample Total DAG Total PA
nmol nmol
si-con 253.4 ± 24.7 1,382.5 ± 42.5
si-DGK- 282.5 ± 5.3 1,308.5 ± 82.6
R59022 197.4 ± 16.5 1,365.4 ± 126.9
The lipids were separated and analyzed by HPLC mass spectrometry, and the 
total amount of each DAG and PA in each sample was determined. si-con, 
siRNA control; si-DGK-, siRNA targeting DGK-.
Table 2. Influence of DGK- on particular DAG and PA lipid species
Lipid Lipid species in cells treated with si-con Lipid species in cells treated with si-DGK- Lipid species in cells treated with R59022
% % %
DAG 36:1 6.09 ± 0.91 8.16 ± 0.42 5.71 ± 0.37
DAG 38:1 0.09 ± 0.01 0.14 ± 0.01b 0.08 ± 0.14
DAG 38:2 0.20 ± 0.07 0.50 ± 0.09b 0.21 ± 0.06
DAG 38:3 1.03 ± 0.64 1.29 ± 0.27 0.71 ± 0.37
DAG 38:4 4.08 ± 0.87 4.40 ± 0.57 5.86 ± 0.45a
DAG 38:5 1.32 ± 0.63 1.01 ± 0.19 0.63 ± 0.24
DAG 38:6 0.68 ± 0.96 0.62 ± 0.16 0.43 ± 0.25
PA 36:1 13.88 ± 0.14 14.65 ± 0.50 13.89 ± 0.51
PA 38:1 0.15 ± 0.01 0.11 ± 0.01b 0.12 ± 0.01b
PA 38:2 1.10 ± 0.21 0.95 ± 0.05 0.99 ± 0.06
PA 38:3 4.82 ± 0.36 3.88 ± 0.35a 3.39 ± 0.24b
PA 38:4 25.28 ± 0.34 21.41 ± 1.12b 15.85 ± 0.97b
PA 38:5 2.59 ± 0.09 2.41 ± 0.14 2.22 ± 0.05b
PA 38:6 1.35 ± 0.03 1.47 ± 0.05 1.32 ± 0.08
A2780 cells were transfected with a non-targeting siRNA (siRNA control [si-con]), an siRNA targeting DGK- (si-DGK-) or treated with 10 µM R59022 for 1 h. Cell 
pellets were collected, and lipids were extracted in the presence of appropriate standards to control for extraction efficiency and to identify the lipids on mass spectrom-
etry. Analysis of each individual molecular species allowed determination of the percentage of each within the total lipid class demonstrating which lipids changed. In 
each sample, 21 distinct DAG species and 32 distinct PA species were identified and quantified; the species not shown in the table demonstrated minimal changes.
aP < 0.05; unpaired t test.
bP < 0.01; unpaired t test.
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Figure 6. RCP’s C2 domain controls recruitment to pseudopod tips. (A and B) A2780 cells were transfected with an siRNA targeting RCP (si-RCP) in 
combination with either GFP, siRNA-resistant GFP-RCPWT (GFP-RCPWT(resc)), or siRNA-resistant GFP-RCP200–649 (GFP-RCP200–649(resc)). In A, 2.5 µM cRGDfV 
was included during the recycling period. Values are means ± SEM of ≥12 replicates. ***, P < 0.0005 GFP versus GFP-RCPWT; Mann–Whitney test. 
##, P < 0.0012 GFP versus GFP-RCP200–649. In B, cells were plated onto the CDM, and videos were collected in the absence () or presence of 2.5 µM cRGDfV 
as for Fig. 3. Pseudopod length was determined as for Fig. 3. Data are represented as box and whiskers plots (black lines show medians; whiskers: 5–95 
percentile); n = 3 independent experiments. ***, P < 0.0001; Mann–Whitney test. (C–F) A2780 cells (C and D) or vector and p53273H-expressing H1299 cells 
(E and F) were transfected with GFP-RCP200–649. Cells were plated onto the CDM, and videos were collected in the absence () or presence of 2.5 µM 
cRGDfV as for Fig. 4 (Videos 9 and 10). Single-section confocal image stills corresponding to individual frames from these videos are presented. 
The yellow arrows indicate the direction of migration, and the portion of the cell within the squares is presented in the bottom images. Bars, 10 µm. 
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pseudopod tips but also to its recruitment from the cytosol to 
vesicular membranes. GFP-RCP200–649, although unable to bind 
to PA and tether vesicles at the extremities of pseudopods, can 
still associate with 51 and be recruited to vesicular structures 
that are located within the cell body and the pseudopod shaft 
(Fig. 6, C and E). We photobleached GFP-RCP200–649 located at 
vesicular structures in the pseudopod shaft near to the tip and 
GFP-RCP200–649, which exhibited a diffuse cytoplasmic distri-
bution at the cell front, and compared the recovery times of these 
two pools of mutant RCP (Fig. S5 B). The recovery time of 
vesicular GFP-RCP200–649 was slightly slower (and the immobile 
fraction marginally larger) than GFP-RCP200–649, which was dif-
fusely cytoplasmic (Figs. 6, D and F; and S5 B). Nevertheless, 
the immobile fraction of vesicular GFP-RCP200–649 (immobile 
fraction ≈ 27–34%) was much less than that of GFP-RCPWT 
at pseudopod tips (immobile fraction ≈ 63–65%; compare 
Fig. 5 [B and C] with Fig. 6 [D and F]). Thus, recruitment 
of RCP from the cytoplasm to vesicles leads to only a small 
decrease in its mobility—indicating that GFP-RCP200–649 can 
exchange quite rapidly between the cytosol and the vesicle 
membrane. On the other hand, GFP-RCPWT is tightly tethered at 
pseudopod tips in a PA/DGK-–dependent fashion and cannot 
exchange rapidly with a cytoplasmic pool of RCP. Collectively, 
these data indicate that PA generated downstream of DGK- 
acts via a mechanism involving RCP’s C2 domain to properly 
recycle 51 integrin and to recruit and tether RCP vesicles to 
the front of long invasive protrusions as cells migrate on CDMs.
At this stage, we assessed whether PA that is generated 
downstream of DGK isoforms other than DGK- or that was pro-
duced via PLDs had a role in RCP-dependent events. Quantitative 
PCR indicated that A2780 cells expressed (in addition to DGK-) 
the , , , , and  isoforms of DGK and that all of these could 
be knocked down using the appropriate siRNA oligonucleotides 
(Fig. S3 E). However, of these DGKs, only DGK- had any signifi-
cant effect on pseudopod extension (Fig. S3 E). Interestingly, we 
recently showed that DGK- is required for anchorage-independent 
growth of Kaposi sarcoma cells (Baldanzi et al., 2011). To look 
at the contribution made by PLDs, we used a primary alcohol 
(butan-1-ol) to inhibit the lipases or a control secondary alcohol 
(butan-2-ol). We found that pseudopod extension (Fig. 3 B) and the 
recruitment of GFP-RCP to the tips of these structures (Fig. S5 A) 
were unaffected by addition of butan-1-ol. These data indicate that 
although DGK- (and possibly DGK-) plays a role in RCP 
function, the majority of DGK isoforms and the PLDs are not re-
quired for RCP-dependent invasive processes in these cell types.
DGK- is necessary for 51-dependent 
tumor cell invasion
Up-regulation of 51 recycling through the RCP pathway 
(whether by inhibition of v3 or by expression of mutant 
p53s) is associated with increased tumor cell invasiveness into 
species within a lipid class function in a distinct manner. In-
deed, many DAG and PA species are metabolic intermediates 
rather than signals (Hodgkin et al., 1998). It has been shown that 
36:1 PA is the major species produced in cells by PLD activity 
(Pettitt et al., 2001). In contrast, 38:4 is the major DAG and PA 
species generated by phosphatidylinositol-4,5 bisphosphate hy-
drolysis and, as such, is predominantly a plasma membrane 
lipid. Similarly, 38:3 and 38:5 DAG and PA are generated 
through this route, though to a lesser extent. Examination of the 
individual DAG and PA species demonstrates that inhibition 
of DGK activity with R59022 and siRNA of DGK- had 
minimal effects upon 36:1 lipids, demonstrating that PLD 
activity was unaffected. The most significant effects of the DGK 
inhibitor and siRNA against DGK- were upon the C38 lipids, 
in particular 38:3, 38:4, and 38:5, pointing to selectivity of the 
kinase for substrate lipids and to its effects being predominantly 
at the plasma membrane. Collectively, these data point to the 
generation of plasma membrane 38:4 PA, in particular, as being 
an important step in 51 recycling. It is perhaps important in 
this regard that 38:4 PA will induce greater membrane fluidity 
and curvature than 38:1 PA or 38:4 DAG.
PA production downstream of DGK- and 
RCP’s C2 domain are required to tether 
recycling vesicles at pseudopod tips
To directly determine whether PA-binding by RCP was re-
quired for 51 recycling and the extension of invasive pseu-
dopods, we deployed a mutant of RCP (RCP200–649), which lacks 
the PA-binding C2 domain (Lindsay and McCaffrey, 2004). 
Although expression of an siRNA-resistant form of full-length 
RCP (RCPWT) effectively restored 51 recycling in RCP 
knockdown cells, RCP200–649 was only partially able to do this, 
indicating that RCP needs to bind PA to properly drive integrin 
trafficking (Figs. 6 A; and S4 C). Consistent with this, expres-
sion of full-length RCP rescued cRGDfV-driven pseudopod 
extension in RCP knockdown cells, but RCP200–649 was ineffec-
tive in this regard (Fig. 6 B). We also investigated the recruit-
ment and tethering of GFP-RCP200–649 at the tips of pseudopods 
in cells in which RCP had not been knocked down. Indeed, 
although v3 inhibition (Fig. 6 C) and mutant p53 expression 
(Fig. 6 E) induced pseudopod elongation in cells expressing 
GFP-RCP200–649 (indicating that RCP200–649 does not exert 
dominant-negative inhibition over endogenous RCP function), 
the truncated RCP mutant was not concentrated at the tips of 
these structures (Fig. 6, C and E; and Videos 9 and 10) despite its 
ability to coimmunoprecipitate with 51 (Fig. S2 D). Moreover, 
FRAP analyses indicated that GFP-RCP200–649 was not tethered 
at the cell front in cRGDfV-treated or p53273H-expressing 
cells (Fig. 6, D and F).
The PA/DGK-–dependent slowing of fluorescence re-
covery may be owing not only to tethering of RCP vesicles at 
(D and F) Photobleaching was performed as described in the Material and methods section. Recovery curves were generated using the FV10-ASW soft-
ware and the immobile fraction (percentage) was extracted from these. In D and F, the recovery curves and immobile fraction of GFP-RCP200–649, which 
was photoactivated in either vesicular structures (vesic.) or diffusely cytoplasmic regions (cyto.), were analyzed either in combination (all) or separately 
(vesicular structures and cytoplasmic regions)—see Fig. S5 B for examples of stills from these videos. The number of cells represented by each analysis is 
depicted in parentheses. Values are means ± SEM.
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Figure 7. DGK- is required for invasion into fibronectin-containing collagen I hydrogels evoked by inhibition of v3 or expression of mutant p53.  
(A–C) A2780 (A), vector, and p53273H-expressing H1299 (B) or MDA-MB-231 (C) cells were transfected with nontargeting siRNA (siRNA control [si-con]) 
or an siRNA targeting DGK- (si-DGK) and plated onto the bottom of collagen I plugs. In A, the collagen plugs were formed in the presence and ab-
sence of 25 µg/ml fibronectin (FN) as indicated, and in B and C, 25 µg/ml fibronectin was included for all conditions. The cells were allowed to invade into 
the plugs for 48 h toward a gradient of 30 ng/ml EGF and 10% FCS. 2.5 µM cRGDfV was added to both the upper and lower chambers of the inverted 
collagen plug as indicated in A. Invading cells were stained with calcein acetoxymethyl ester and visualized by confocal microscopy. Serial optical sections 
were captured at 15-µm intervals and are presented as a sequence in which the individual optical sections are placed alongside one another with increas-
ing depth from left to right as indicated. Migration was quantitated by measuring the fluorescence intensity of cells penetrating the collagen/fibronectin to 
depths of 60 µm (A) or 30 µm (B and C) and greater and expressing this as a percentage of the total fluorescence intensity of all cells within the plug. Data 
are represented as box and whiskers plot (black lines show medians; whiskers show minimum to maximum values); n = 3 independent experiments. 
***, P < 0.0001; Mann–Whitney test.
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plugs of collagen I or Matrigel (Caswell et al., 2008; Muller 
et al., 2009). Moreover, RCP-dependent invasion is only apparent 
after addition of fibronectin to the ECM plug, thus highlighting 
the requirement for 51 in this type of cell migration. Con-
sistent with our previous observations, we found that inhibition 
of v3 or expression of mutant p53 increased invasion into 
collagen I plugs and that this was particularly apparent when 
fibronectin was added to the matrix (Fig. 7, A and B). Interest-
ingly, invasion that was driven by inhibition of v3 or by ex-
pression of mutant p53 (and that was fibronectin dependent) was 
strongly opposed by siRNA of DGK-, whereas the basal inva-
siveness of A2780 and H1299 cells was not significantly affected 
by knockdown of the kinase (Fig. 7, A and B). Furthermore, inva-
sion of MDA-MB-231 breast carcinoma cells (that endogenously 
express the DNA-binding R280K mutant of p53) into fibronectin- 
containing collagen I plugs was inhibited by siRNA of DGK- 
(Figs. 7 C; and S1 C) to a similar extent as by knockdown of mu-
tant p53 (not depicted; Muller et al., 2009) in this cell type.
A membrane-anchored DGK- promotes 
recruitment of RCP to invasive pseudopods 
and drives RCP-dependent invasion
Although DGK- itself was not activated by inhibition of v3 
or by expression of mutant p53s (Fig. S1, F and G), it was clear 
that addition of exogenous PA (but not DAG or lyso-PA) was 
able to drive pseudopod extension (Fig. 8 A). Moreover, this 
was not opposed by pharmacological inhibition of DGK, indi-
cating that PA is acting downstream of the kinase (Fig. 8 A). 
A mutant of DGK- containing the Src myristoylation sequence 
at its C terminus (myr–DGK-) has previously been shown to 
be constitutively membrane-associated, catalytically active, and 
able to induce membrane ruffles and migration of epithelial 
cells in the absence of chemotactic factors (Baldanzi et al., 
2008; Chianale et al., 2010). Indeed, expression of myr-DGK- 
increased 51 recycling even in the absence of v3 inhibi-
tion (Fig. 8 B). Strikingly, expression of myr–DGK- promoted 
the extension of very long pseudopods when cells were migrat-
ing on the CDM (Fig. 8, C and D), and large numbers of RCP 
vesicles were concentrated toward the tips of these structures 
(Fig. 8 D). Moreover, myr–DGK-–driven pseudopod extension 
was opposed by knockdown of RCP, and this was rescued by 
expression of an siRNA-resistant form of full-length RCP (RCPWT) 
but not by the RCP200–649 mutant that lacks the PA-binding 
C2 domain (Fig. 8 C). Consistently, myr–DGK- increased inva-
siveness of A2780 cells through collagen I plugs, in a way that 
required addition of fibronectin to the ECM (Fig. 8 F), and this 
was completely opposed by siRNA of RCP (Fig. 8, E and G). 
Collectively, these data show that PA production downstream 
of DGK- drives the invasive behavior of tumor cells and that 
this is achieved through the control of RCP function and its 
regulation of 51 integrin recycling.
Discussion
Tumor cells expressing gain-of-function p53 mutants have 
altered cell migration and increased invasiveness (Adorno et al., 
2009; Muller et al., 2009), and similar changes in tumor cell 
motility may be evoked by inhibition of v3 integrin (Caswell 
et al., 2008). These alterations to cell migration depend on the 
ECM environment in which cell movement is studied. For 
instance, on plastic surfaces, mutant p53 expression and inhibi-
tion of v3 both decrease the persistence of migration. How-
ever, on CDMs, migratory persistence is not affected, but 
expression of mutant p53 or inhibition of v3 drives extension 
of long pseudopods in the direction of migration. Importantly, 
in 3D microenvironments, mutant p53 and inhibition of v3 
both drive increased invasiveness in a way that is dependent on 
51 and its ligand fibronectin. However, it is clear that, irre-
spective of the microenvironmental context, increased RCP-
dependent recycling of 51 integrin underlies this altered 
migratory behavior. This study describes a role played by DGK-  
in RCP function, and—importantly—knockdown or inhibition 
of DGK- prevents RCP-dependent receptor recycling and cell 
migration but has no effect on related events that are RCP inde-
pendent. Critical to RCP’s ability to localize to the tips of inva-
sive structures is the PA-binding C2 domain that lies within 
its N-terminal region. Moreover, expression of a constitutively 
active plasma membrane–anchored DGK- mutant is a power-
ful driver of tumor cell invasion in a way that is dependent on 
RCP and the ability of RCP to bind to PA. These data show that the 
role of DGK- during the invasion of mutant p53-expressing 
cells is to generate PA to enable RCP function, and without 
DGK-, the migratory behavior of mutant p53-expressing 
tumor cells is indistinguishable from their p53-null counterparts.
PA can be generated by the activity of either PLDs or 
DGKs, and both these enzyme families have been linked to 
membrane trafficking events (Jenkins and Frohman, 2005; 
Mérida et al., 2008). PA generation has a well-established role 
in the budding of transport vesicles from several cellular mem-
branes, including the plasma membrane and Golgi complex. 
Much of PA’s ability to promote vesicle budding is thought to 
be caused by the curvature that the lipid imparts when generated 
in restricted membrane regions, and a recent study has shown that 
this is mediated via PA’s collaboration with membrane-binding 
proteins, such as BARS, to bend membranes to promote vesicle 
fission (Yang et al., 2008). Indeed, PA directly binds proteins, 
such as Sos, and this interaction mediates the potentiation of 
Ras signaling by PLD (Zhao et al., 2007). Furthermore, several 
proteins known to control membrane traffic, such as Arfs1 and 6, 
PIP4K, and NSF, have been reported to bind to and/or be 
activated by PA (Ktistakis et al., 2003). The C2 domains of the 
class I FIPs—RCP, FIP2, and Rip11—bind to PA (Lindsay and 
McCaffrey, 2004), so potentially, these Rab11 effectors may be 
controlled by PLDs and/or DGKs. However, of the class I FIPs, 
only RCP is capable of binding to 51 (Caswell et al., 2008), 
thus highlighting a potentially selective connection between 
PA signaling and integrin trafficking. So how do PA and RCP 
collaborate in integrin recycling? DGK- activity and the C2 
domain are not required for RCP to bind to 51 (Fig. S3 D) or 
Rab11 nor for its recruitment to endosomal membranes (Lindsay 
and McCaffrey, 2004). However, deletion of the C2 domain or 
inhibition of DGK- signaling reduces the number of RCP-
positive structures that are tethered at pseudopod tips and 
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Figure 8. myr–DGK- promotes RCP-dependent integrin recycling, invasion, and recruitment of RCP to pseudopod tips. (A) A2780 cells were plated onto 
the CDM, time-lapse videos were collected in the absence (–) or presence of lyso-PA (LPA), DAG, PA, and R59022 (all at 10 µM), and pseudopod length 
was determined as for Fig. 3. Blue boxes indicate addition of PA. Data are represented as box and whiskers plots (black lines show medians; whiskers: 
5–95 percentile); n = 3 independent experiments. ***, P < 0.0001; Mann–Whitney test. (B) A2780 cells were transfected with myr–DGK- or pMT2 
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correspondingly increases the vesicle population in the perinu-
clear region without apparently restricting the overall mobility of 
RCP endosomes and their ability to move up and down the 
pseudopod shaft. An immunofluorescence study indicates that 
active DGK- is localized to the plasma membrane (Baldanzi 
et al., 2008), and consistently, we cannot detect DGK- local-
ized to RCP endosomes (Fig. S1 H). Moreover, myr–DGK-, 
which so potently drives RCP-dependent pseudopodial exten-
sion and invasion, is localized exclusively to the plasma mem-
brane (unpublished data; Baldanzi et al., 2008; Chianale et al., 
2010), indicating that it is here that PA acts to influence RCP 
function. Established vesicle tethers commonly possess a Rab 
GTPase/cargo-binding portion, which is linked by an extended 
coiled-coil region to a domain that senses membrane curvature 
(Brown and Pfeffer, 2010). Collectively, these observations 
suggest that RCP may function as a vesicle tether that interacts 
C terminally with Rab11 and the integrin cargo vesicle and 
N terminally with a highly concave PA-rich region of the plasma 
membrane at the pseudopod tip. Indeed, the selective genera-
tion of longer chain, more unsaturated PA species (38:3, 38:4, 
and 38:5), such as we have detected in our mass spectrometry 
analyses, would be expected to promote localized membrane 
curvature. Further work is required to determine precisely where 
in the cell DGK- acts to produce PA during migration and the 
role played by RCP in recruiting and tethering integrin transport 
vesicles at the tips of invading pseudopods.
Several groups have shown that PA production down-
stream of PLDs contributes to endosomal transport and also to 
actin remodelling that is associated with cell migration. How-
ever, we show that siRNA knockdown or pharmacological inhi-
bition of DGK- consistently opposes recruitment of RCP to 
pseudopod tips, whereas treatment of cells with butan-1-ol to 
inhibit PLDs has no effect on these processes, indicating that 
DGK- is more important as a source of PA to enable RCP 
function than are PLDs; a conclusion supported by there being 
no change in 38:1 PA in our mass spectrometry analyses. More-
over, the way in which DGK- influences tumor cell migration 
is not implemented via an overarching requirement for the 
kinase in cell motility—indeed DGK- knockdown A2780 and 
H1299 cells migrate persistently on plastic surfaces, indicating 
that the cell’s migratory machinery is working properly—but 
by controlling RCP/51-dependent events that dictate the 
particular mode of migration adopted by the cell. 51 integrin 
signaling through RhoA stimulates rapid random migration on 
2D surfaces (Danen et al., 2005), and we have shown that 
up-regulation of 51 recycling evokes Rho-dependent motile 
responses, indicating that RCP recycling enhances 51’s com-
munication with RhoA (White et al., 2007). Consistently, we find 
that the ability of cRGDfV and mutant p53 to increase random 
cell migration (a DGK-–dependent process) is opposed by 
inhibition of Rho kinase (Fig. S3, C and D). DGK- has pre-
viously been shown to link HGF receptor activation to membrane 
targeting and the protrusive activity of Rac in MDCK epithelial 
cells (Chianale et al., 2007). This occurs via a mechanism 
whereby PA production downstream of DGK- acts on atypical 
PKC, which, in turn, allows Rac release from Rho GDP 
dissociation inhibitor and delivery to the plasma membrane 
(Chianale et al., 2010). However, the migration of nontrans-
formed epithelial cells and that of tumor cells is controlled dif-
ferently, and further work will be needed to determine the 
relationship between HGF-induced Rac activation in epithelial 
cells and DGK-/RCP/51-dependent RhoA-associated ran-
dom migration in mutant p53-expressing tumor cells.
DGK- has been linked to both positive and negative roles 
in cancer. On the one hand, a study in lung cancer has identified 
a correlation between elevated DGK- expression and good 
prognosis (Berrar et al., 2005). This indicates a potential tumor 
suppressor role for DGK- and may be related to its ability 
to oppose DAG signaling. On the other hand, many studies indi-
cate that DGK- contributes to cancer progression. For in-
stance, DGK- is up-regulated in lymph node metastases with 
respect to primary breast tumors, indicating that it may be a 
prometastatic gene (Hao et al., 2004). Gain-of-function mutants 
of p53 are clearly prometastatic, and interestingly, we find that 
DGK- is required for these p53 mutants to influence tumor cell 
migration and invasion. Mutant p53s act by inhibiting p63 to 
drive association of RCP with internalized 51 integrin 
and EGF receptor (EGFR), and these processes do not re-
quire DGK-. However, DGK- is required for subsequent 
RCP-dependent delivery of 51 and EGFR (Fig. S4 D) to 
the plasma membrane. This indicates that, although DGK- 
is neither activated nor up-regulated by mutant p53, the kinase 
forms an essential part of the mutant p53–RCP–integrin axis, 
as it is required for RCP-recycling vesicles to be recruited to 
the appropriate plasma membrane regions during invasive cell 
migration (Fig. 9).
These findings not only offer mechanistic insight into 
the control of tumor cell invasion and motility but also pro-
vide evidence for an essential role for DGK- and specific 
molecular species of PA in delivery of recycling vesicles to 
the plasma membrane at the tips of invasive pseudopodial 
structures. Whether DGK-–dependent integrin recycling 
impacts tumor invasion in vivo remains to be determined, 
but the contribution made by this kinase to integrin traffick-
ing and signaling needs to be considered in the context of 
cancer metastasis.
(empty vector), and the recycling of 51 was determined as for Fig. 1. **, P = 0.004; ***, P = 0.0008; Mann–Whitney test. (C) A2780 cells were trans-
fected with myr–DGK- or pMT2 together with nontargeting siRNA (siRNA control [si-con]) or an siRNA targeting RCP (si-RCP) in combination with GFP, 
siRNA-resistant GFP-RCPWT (GFP-RCPWT(resc)), or siRNA-resistant GFP-RCP200–649 (GFP-RCP200–649(resc)). Cells were plated onto the CDM, and pseudopod 
length was determined as for Fig. 3. ***, P = 0.0008; Mann–Whitney test. (D) A2780 cells were transfected with myr–DGK- or pMT2 (empty vector) in 
combination with GFP-RCP. Transfected cells were plated onto CDM, and videos were captured as for Fig. 4. Representative stills are displayed. The yellow 
arrows indicate the direction of migration and the portion of the cell within the white square, which is presented at the bottom. Bar, 20 µm. (E–G) A2780 cells 
were transfected with myr–DGK- or pMT2 in combination with either nontargeting siRNA or an siRNA targeting RCP and plated into inverted invasion 
assays in the presence (E and G) or absence (F) of 25 µg/ml fibronectin (FN) as indicated. Invasion was determined as for Fig. 7. Data are represented as 
box and whiskers plots (black lines show medians; whiskers: minimum to maximum). ***, P < 0.0001; Mann–Whitney test. Values are means ± SEM.
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mutations introduced into the GFP-RCPWT and GFP-RCP200–649 rescue 
constructs were T1757C, C1763T, and C1769T.
Immunoprecipitation and Western blotting
Cells were lysed in lysis buffer (200 mM NaCl, 75 mM Tris-HCl, pH 7, 
15 mM NaF, 1.5 mM Na3VO4, 7.5 mM EDTA, 7.5 mM EGTA, 0.15% 
[vol/vol] Tween 20, 50 µg/ml leupeptin, 50 µg/ml aprotinin, and 1 mM 
4-(2-aminoethyl)-benzenesulfonyl fluoride). Lysates were passed three times 
through a 27-gauge needle and clarified by centrifugation at 10,000 g for 
10 min at 4°C. Magnetic beads conjugated to sheep anti–mouse IgG 
(Invitrogen) were bound to the anti-GFP (Abcam) antibody. Antibody-coated 
beads were incubated with lysates for 2 h at 4°C with constant rotation. 
Unbound proteins were removed by extensive washing in lysis buffer, and 
specifically associated proteins were eluted from the beads by boiling for 
10 min in Laemmli sample buffer. Proteins were resolved by SDS-PAGE 
and analyzed by Western blotting as described previously (Roberts et al., 
2001). Antibodies used for Western blotting were as follows: anti–5 inte-
grin (BD), anti-RCP (in-house rabbit antibody raised against RCP379–649), 
anti-GFP (Abcam), and anti–-actin (Sigma-Aldrich). Monoclonal mouse anti–
DGK- was provided by W.J. van Blitterswijk (Netherlands Cancer Institute, 
Amsterdam, Netherlands).
DGK assay
DGK- was assayed as previously described (Cutrupi et al., 2000). In brief, 
anti-Myc (Santa Crutz Biotechnology, Inc.) or anti–DGK- (Abcam) immuno-
precipitates were incubated with the immunocomplexes at 30°C with 3 mg/ml 
sn-1,2-dioleiyl-glycerol (Sigma-Aldrich), 5 mM ATP, 10 µCi/ml -[32P]ATP 
(PerkinElmer), 10 mM MgCl2, 1 mM ZnCl2, and 1.2 mM EGTA in 7.5 mM 
Hepes, pH 8. After 5 min, the reaction was stopped with 1 N HCl, and lipids 
were extracted with chloroform/methanol at 1:1 and separated by TLC on 
sheets coated with 1.3% potassium oxalate and 5 mM EDTA/methanol (3:2) 
in chloroform/methanol/water/32% ammonium hydroxide (60:47:10:3). 
-[32P]PA was identified by co-migration with nonradioactive PA standards 
stained by incubation in an iodine chamber. Radioactive signals were de-
tected and quantified with a molecular imager (GS-250; Bio-Rad Laborato-
ries) and Phosphor Analyst software (Bio-Rad Laboratories).
Mass spectrometric determination of DAG and PA species
Cell pellets were spiked with 12:0/12:0-DAG and 12:0/12:0-PA (100 
ng each) as internal standards and extracted with 4 ml chloroform/2 ml 
methanol/2 ml of 0.88% NaCl followed by a second extraction of 
Materials and methods
Cell culture and transfection
Stable clones of H1299 vector– and p53273H-expressing cells were gener-
ated by transfecting an empty vector (PCB6+) or construct expressing 
p53273H (in PCB6+) with transfection reagent (Effectene; QIAGEN). Cells 
were selected by medium containing 600 mg/ml G418. The p53273H 
mutant was created using site-directed mutagenesis as described pre-
viously (Muller et al., 2009). A2780 cells were grown in RPMI 1640 con-
taining 10% serum, and H1299 and MDA-MB-231 cells were grown in 
Dulbecco’s minimal essential medium containing 10% serum at 37°C and 
10% CO2. All constructs and siRNA oligonucleotides were transfected into 
cells using the transfection system (Nucleofector Solution T, program A-23, 
for A2780 cells and Nucleofector Solution V, program X-01, for H1299 cells; 
Lonza) according to the manufacturer’s instruction. DGK inhibitors I 
(R59022) and II (R59949), both obtained from Sigma-Aldrich, were used 
in the presence and absence of serum, respectively. R59949, although 
more specific for DGKs, cannot be used in the presence of serum owing to 
its tendency to be sequestered onto serum lipids. The recycling assays were 
performed on serum-starved cells, whereas all other experiments were con-
ducted in the presence of serum. C6-PA, C6–lyso-PA, and C8-DAG were 
purchased from Avanti Polar Lipids, Inc. Lipids were dissolved in chloroform, 
dried under nitrogen, and then dissolved in PBS by sonication before dilution 
in serum-containing medium to the appropriate concentration (10 µM). 
siRNA targeting DGK-, -, -, -, and - and primers used for RT-PCR were 
previously described in Baldanzi et al. (2011).
Plasmid constructs and siRNA sequences
The constructs were previously described as follows: pEGFP-C3 RCP was 
generated by subcloning the open reading frame of RCP from pGADGH 
RCP into pEGFP-C3 (Damiani et al., 2004), GFP-RCP200–649 was con-
structed by ligating the SalI–BamHI fragment from pEGFP-C3 RCP into the 
SalI–BamHI site of pEGFP-C1 (Lindsay and McCaffrey, 2004), and myc–DGK- 
was generating by cloning DGK- cDNA into pMT2 expression vector 
(Cutrupi et al., 2000); to obtain myr-myc–DGK-, the N terminus of myc–
DGK- was modified by adding the Src myristoylation sequence (Baldanzi 
et al., 2008). The siRNA sequence targeting DGK- was 5-GGUCAGUG-
AUGUCCUAAAG-3, and the silent mutations introduced into the DGK- 
PMT2 rescue construct were C345A, T351C, and A357C. The siRNA 
targeting RCP was 5-AGUGAGAACUUGAACAAUG-3, and the silent 
Figure 9. Schematic to summarize DGK-’s role in RCP-dependent events. Inhibition of v3 or expression of mutant p53273H promotes recruitment of 
RCP to endosomal 51. Association of 51 with RCP is not a DGK-dependent event and does not require RCP’s PA-binding C2 domain. RCP/integrin 
recycling vesicles can then move up and down the pseudopod shaft, and the role of DGK- is to generate PA species that enable the tethering of RCP at 
pseudopod tips, an event that requires RCP’s C2 domain. Of the lipid species detected in the mass spectrometric analysis, inhibition or silencing of DGK- 
most significantly affects the interconversion of 38:4 DAG to 38:4 PA. The 38:4 species of PA is therefore depicted as the most likely to be involved in 
tethering RCP at pseudopod tips.
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upper phase with 3 ml synthetic lower phase of chloroform/methanol/0.88% 
NaCl at 2:1:1. The combined lower phase of lipid extract was dried at 
room temperature under a vacuum, dissolved in 50 µl chloroform/meth-
anol at 1:1, and subjected to liquid chromatography–mass spectrome-
try analysis using a liquid chromatography–tandem mass spectrometry 
system (IT-TOF; Shimadzu). Accurate mass (with mass accuracy of 5 
ppm) and tandem mass spectrometry were used for molecular species 
identification and quantification. All solvents used for lipid extraction 
and liquid chromatography–tandem mass spectrometry analysis were 
liquid chromatography–mass spectrometry grade obtained from Thermo 
Fisher Scientific.
Generation of CDM
The CDM was generated as described previously (Cukierman et al., 2001). In 
brief, gelatin-coated tissue cultureware was cross-linked with glutaralde-
hyde, quenched, and equilibrated in DME containing 10% FCS. Primary 
cultured human dermal fibroblasts were seeded at near confluence (2 × 104 
cells/cm2) and grown for 10 d in DME containing 10% FCS and 50 µg/ml 
ascorbic acid. Matrices were denuded of living cells by incubation with 
PBS containing 20 mM NH4OH and 0.5% Triton X-100, and DNA residue 
was removed by incubation with DNase I. Matrices were blocked with 
0.1% heat-denatured BSA before seeding of cells.
Microscopy
For time-lapse imaging, cells were plated onto 6-well plates coated with 
CDM and incubated at 37°C until cells adhered and began migrating (4 h). 
Cells were imaged using a 10× Plan Fluor objective, NA 0.3, and an in-
verted microscope (TE200; Nikon) with a camera (CoolSNAP HQ; Photo-
metrics) and Metamorph software (Molecular Devices) in an atmosphere of 
5% CO2 at 37°C for 16 h. Videos were generated using ImageJ (National 
Institutes of Health). The movement of individual cells was followed using 
ImageJ software, and the forward migration index was calculated by the 
Chemotaxis and Migration Tool from ImageJ (version 1.01). For fluores-
cence time-lapse imaging, cells were plated onto glass-bottomed 3-cm 
plates coated with CDM and incubated at 37°C for 24 h. Cells were imaged 
using a U Plan S Apochromat 60× objective, NA 1.35, and an inverted 
confocal microscope (FluoView FV1000; Olympus) with FluoView software 
(Olympus) in an atmosphere of 5% CO2 at 37°C. Brightness and contrast 
of the videos and stills from the videos were adjusted using ImageJ. No 
nonlinear adjustments were used.
FRAP
0.75 × 105 cells were seeded onto CDM and treated as indicated. The 
experiments were performed using a confocal microscope (FV1000). Effective 
photobleaching was achieved with 18% 405-nm laser power with one frame 
bleach time. Images were captured every second for 60 s. Up to 30 cells per 
condition were measured. Analysis of unbleached regions showed that 
total photobleaching was <6% over the time course of recovery.
Receptor internalization and recycling assays
Internalization. Cells were serum starved for 1–2 h, transferred to ice, 
washed twice in cold PBS, and surface labeled at 4°C with 0.133 mg/ml 
NHS-SS-Biotin (Thermo Fisher Scientific) in PBS for 1 h. Labeled cells were 
washed in cold PBS and transferred to serum-free medium at 37°C in the 
presence of 0.6 mM primaquine to allow internalization. After internaliza-
tion, the medium was aspirated, and the dishes were rapidly transferred 
to ice and washed twice with ice-cold PBS. Biotin was removed from pro-
teins remaining at the cell surface by incubation with a solution containing 
20 mM MesNa (sodium 2-mercaptoethanesulphonate) in 50 mM Tris, 
pH 8.6, and 100 mM NaCl for 15 min at 4°C. MesNa was quenched by 
addition of 20 mM iodoacetamide for 10 min, and the cells were lysed 
in 200 mM NaCl, 75 mM Tris, 15 mM NaF, 1.5 mM Na3VO4, 7.5 mM 
EDTA, 7.5 mM EGTA, 1.5% Triton X-100, 0.75% IGEPAL CA-630, 
50 µg/ml leupeptin, 50 µg/ml aprotinin, and 1 mM 4-(2-aminoethyl)benzyne-
sulphonyl fluoride. Lysates were passed through a 25-guage needle and 
clarified by centrifugation at 10,000 g for 10 min. Levels of biotinyl-
ated integrin were determined by capture ELISA as described previously 
(Roberts et al., 2001). In brief, 96-well plates (MaxiSorp; Life Technologies) 
were coated overnight with 5 µg/ml anti–5 integrin antibody (no. 555651) 
in 0.05 M Na2CO3, pH 9.6, at 4°C and blocked in PBS containing 0.05% 
Tween 20 (PBS-T) with 5% BSA for 1 h at room temperature. Integrins were 
captured by overnight incubation of 50 µl cell lysate at 4°C. Unbound mate-
rial was removed by extensive washing with PBS-T, and wells were incubated 
with streptavidin-conjugated horseradish peroxidase (GE Healthcare) in PBS-T 
containing 1% BSA for 1 h at 4°C. After further washing, biotinylated integ-
rins were detected by chromogenic reaction with orthophenylenediamine.
Recycling. After surface labeling, cells were transferred to serum-free 
medium for 30 min at 37°C to allow internalization of tracer. Cells were 
returned to ice and washed twice with ice-cold PBS, and biotin was re-
moved from proteins remaining at the cell surface by reduction with 
MesNa. The internalized fraction was then chased from the cells by return-
ing them to 37°C in serum-free medium. After recycling, the cells were re-
turned to ice, and biotin was removed from recycled proteins by a second 
reduction with MesNa. Biotinylated integrins were then determined by cap-
ture ELISA as described previously (Roberts et al., 2001). The antibodies 
used for capture ELISA detection of 51 integrin (clone VC5) and EGFR 
(clone EGFR.1) were obtained from BD. cRGDfNMeV and cRGDfV were 
added to the cells only during the recycling period.
Transferrin recycling. To measure recycling of internalized transferrin, se-
rum-starved cells were incubated with 125I-transferrin (0.1 µCi/well) for 1 h at 
4°C in PBS with 1% BSA. The tracer was allowed to internalize for 30 min at 
37°C. Tracer remaining at the cell surface was removed by incubation with an 
excess of 10 µg/ml of unlabeled transferrin at 4°C for 1 h, and the tracer was 
allowed to recycle at 37°C in serum-free medium supplemented with 10 µg/ml 
of unlabeled transferrin. To provide a positive control for inhibition of recy-
cling, 0.3 mM primaquine was included in the recycling period only, and 120 
µM chloroquine was added during both the internalization and recycling peri-
ods. The quantity of 125I recycled into the medium is expressed as a percent-
age of the number of counts incorporated during the internalization period.
Inverted invasion assays
Inverted collagen I invasion assays were performed as described pre-
viously (Hennigan et al., 1994; Caswell et al., 2008). In brief, collagen 
supplemented with 25 µg/ml fibronectin as indicated was allowed to 
polymerize in transwell inserts (Corning) for 1 h at 37°C, cells were seeded 
on the opposite side of the filter, and 10% FBS + 30 ng/ml EGF was 
placed on top of the matrix. 2.5 µM cRGDfV was added to the collagen 
before plug polymerization and also in the medium. 48 h after seeding, 
migrating cells were stained with calcein acetoxymethyl ester and visualized 
by confocal microscopy with serial optical sections being captured at 15-µm 
intervals with a microscope (20× HC Plan Fluotar objective, NA 0.5; SP2; 
Leica) using LCS software (Leica).
Online supplemental material
Fig. S1 shows that the expression of DGK- is reduced upon transfection of 
an siRNA against DGK- in A2780, H1299, and MDA-MB-231 cells, DGK- 
is not required for the internalization of 51 or TfnR, and inhibition of 
v3 or expression of mutant p53 did not affect the enzymatic activity or the 
localization of DGK-. Fig. S2 shows that DGK activity and the C2 domain 
of RCP are not required for the interaction of RCP with 51. Fig. S3 shows 
the effects of DGK- knockdown on speed and persistence of cell migration, 
the effects of Rho kinase inhibition on random migration induced by inhibi-
tion of v3 or expression of mutant p53, and the role of other DGK iso-
forms in pseudopod elongation. Fig. S4 shows that the accumulation of RCP 
at the tip of pseudopods does not reflect increased cytoplasmic volume at 
these cellular extremities. Fig. S5 shows that PLD activity is not required for 
RCP recruitment to pseudopod tips. Videos 1–3 show GFP-actin localization 
in A2780 cells transfected with a nontargeting siRNA (Video 1), treated with 
cRGDfNMeV in presence of a nontargeting siRNA (Video 2), or an siRNA 
against DGK- (Video 3). Videos 4 and 5 show GFP-RCP localization in 
A2780 cells treated with cRGDfV and transfected with a nontargeting siRNA 
(Video 4) or an siRNA against DGK- (Video 5). Videos 6 and 7 show GFP-
RCP localization in p53273H-expressing H1299 cells transfected with a non-
targeting siRNA (Video 6) or an siRNA against DGK- (Video 7). Video 8 
shows the recovery from photobleaching of GFP-RCP in A2780 cells trans-
fected with a nontargeting siRNA or an siRNA against DGK-. Videos 9 and 
10 show the localization of GFP-RCP200–649 in A2780 (Video 9) and 
p53273H-expressing H1299 cells (Video 10). Online supplemental material is 
available at http://www.jcb.org/cgi/content/full/jcb.201109112/DC1.
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